Angiooedema under ACE inhibitors and angiotensin II-receptor antagonists: Analysis of 98 cases;Angioodem unter ACE-hemmern und angiotensin-II-rezeptor-antagonisten: Analyse von 98 fallen

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 9, 1999, Pages 362-369

  Schuster, C ^a   Reinhart, W H ^a   Hartmann, K ^b   Kubn, M ^a,b,c  

^a Medizinische Klinik

^b Schweizerische A ^*  (Switzerland)

^c Schweizerische A   (Switzerland)

Author keywords

ACE inhibitors; Angiooedema; Angiotensin II receptor antagonists; Swiss Drug Monitoring Centre

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN RECEPTOR;

ANGIONEUROTIC EDEMA; ARTICLE; DISEASE COURSE; DRUG SURVEILLANCE PROGRAM; HUMAN; INTUBATION; LATENT PERIOD; MAJOR CLINICAL STUDY; RECURRENT DISEASE; SWITZERLAND; ADULT; AGED; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FEMALE; MALE; MIDDLE AGED;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; SWITZERLAND;

EID: 0033528331     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980;116:902-5.
2. Karch FE, Lasagna L. Adverse drug reaction. JAMA 1975; 234:1236-41.
3. Hartmann K, Kuhn M, Gartmann J. Erfassung von neuen, unbekannten und seltenen uaerwünschten Arzneimittelwirkungen im Spontanmeldesystem. Schweiz Med Wochenschr 1992;122:1409-13.
4. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992;117:234-42.
5. SADRAC (Swedish Adverse Drug Reactions Advisory Committee). Medical Products Agency, Läkemedelsverket, Husargatan 8, 75103 Uppsala, Sweden.
6. Lareb. Netherlands Pharmacovigilance Foundation. Goudsbloemvallei 7, 5237 MH ,s-Hertogenbosch.
7. Danish Medicines Agendy, Frederikssundsvej 378,DK-2700 Bronshoj.
8. Merck Sharp &: Dohme-Chibret AG. Firmeninterne Datenbank. Schaffhauserstr. 136, 8252 Glattburg, Switzerland. Publiziert in: (1.) |29|, Boxer M. Accupril- and Cozaar-induced angioedema in the same patient. J Allergy Clin Immunol 1996;98:471. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997;90:552-3.
9. Merck Sharp &: Dohme-Chibret AG. Firmeninterne Datenbank. Schaffhauserstr. 136, 8252 Glattburg, Switzerland. Publiziert in: (1.) |29|, Boxer M. Accupril- and Cozaar-induced angioedema in the same patient. J Allergy Clin Immunol 1996;98:471. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997;90:552-3.
10. Merck Sharp &: Dohme-Chibret AG. Firmeninterne Datenbank. Schaffhauserstr. 136, 8252 Glattburg, Switzerland. Publiziert in: (1.) |29|, Boxer M. Accupril- and Cozaar-induced angioedema in the same patient. J Allergy Clin Immunol 1996;98:471. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997;90:552-3.
11. Arzneimittelkommission der Deutschen Ärzteschaft. Fachausschuss der Bundesärztekammer, Aachenerstr. 233-37, Köln.
12. Sabroe RA, Kobza Black A. Angiotensin-converting enzyme (ACE) inhibitors and angioedema. B J Dermatol 1997;136: 153-8.
13. Wood S, Mann R, Rawlins M. Angioedema and urticaria associated with angiotensin converting enzyme inhibitors. Br Med J 1987;294:91-2.
14. Korman NJ, Eyre RW, Zone J, Stanley JR. Drug induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol (United States) 1991; 96:273-6.
15. Kallenberg CG. Severe cutaneous reactions to captopril [letter], Br Med J 1985;290:1829.
16. Auchincloss JH, Streeten DHP, Gilbert R, Peppi D. Dyspnea in patients with hyperbradykininism and excessive venous pooling. Am J Med 1986;81:260-6.
17. Anderson MW, deShazo RD. Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codein, and histamine. J Allergy Clin Immunol 1990;85:856-8.
18. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agosroni A, Plasma bradykinin in angio-oedema. Lancet 1998;351:1693-7.
19. Kostis JB, Shelton B, Gosselin G, et al. Adverse effects of enalapril in the Study of Left Ventricular Dysfunction (SOIVD). Am Heart J 1996;131:350-5.
20. Vleeming W, van Amsterdam JGC, Stricker BHC, de Wildt DJ. ACE inhibitor induced angioedema. Incidence, prevention and management. Drug Safety 1998;18:171-88.
21. Slater EE, Merill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH, Ewan PW. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967-70.
22. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-induced angioedema. Clin Pharmacol Ther 1996;60:8-13.
23. Diehl KL, Wernze H. Angioneurotisches Ödem durch Angiotensin-Konversionsenzym-Hemmer. Dtsch Med Wochenschr 1992;117:727-32.
24. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andrén L, Wiholm BE, Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. Br Med J 1992;304: 941-6.
25. Cameron HA, Higgins TJ. Clinical experience with lisinopril. Observations on safety and tolerability. J Hum Hypertens 1989;3:177-86.
26. Chu TJ, Chow N. Adverse effects of ACE inhibitors |letter|. Ann Intern Med 1993;118:314.
27. Dyer PD. Late-onset angioedema after interruption of angiotensin converting enzyme inhibitor therapy. J Allergy Clin Immunol 1994;93:947-8.
28. Frontera Y, Piecuch JF. Multiple episodes of angioedema associated with lisinopril, an ACE inhibitor. J Am Dent Ass 1995;126:217-20.
29. Schiller PI, Messmer SL, Haefeli WE, Schlienger RG, Bircher AJ. Angiotensin-converting enzyme inhibitor-induced angioedema: late onset, irregular course, and potential role of triggers. Allergy (Denmark) 1997;52:432-5.
30. Abdelmalek MF, Douglas DD. Lisinopril-induced isolated visceral angioedema: a review of ACE-inhibitor-induced small bowel angioedema. Dig Dis Sci 1997;42:847-50.
31. Acker CG, Greenberg A. Angioedema induced by the angiotensin II blocker losartan. N Engl J Med 1995;333:1572.
32. Frye CB, Pettigrew TJ. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy 1998;18:866-8.